Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-9942
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review ; volume:70 ; number:1 ; day:5 ; month:9 ; year:2022 ; pages:1-9 ; date:12.2022
Egyptian Pediatric Association gazette / Egyptian Paediatric Association ; 70, Heft 1 (5.9.2022), 1-9, 12.2022
- Urheber
-
Le Thy, Phuong Anh
Hoang Thi, Thuy Yen
Tran, Kiem Hao
Nguyen, Huu Son
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43054-022-00117-y
- URN
-
urn:nbn:de:101:1-2022111721110081992101
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Le Thy, Phuong Anh
- Hoang Thi, Thuy Yen
- Tran, Kiem Hao
- Nguyen, Huu Son
- SpringerLink (Online service)
Ähnliche Objekte (12)
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD
Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients
Urokinase-type plasminogen activator receptor in vascular calcification
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD
Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients
Urokinase-type plasminogen activator receptor in vascular calcification
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD
Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients
Urokinase-type plasminogen activator receptor in vascular calcification
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden